
Possible therapeutic effects of myxobacterial metabolites on type I Gaucher disease
Keywords: GD, Gaucher disease; GluCer, glucosylceramide; Bax, Bcl-2-associated X protein; ATP-CS, ATP-citrate synthase; E3BP, E3-binding protein; ACAT1, acetyl-coenzyme A acetyltransferase 1; ER, endoplasmic reticulumGaucher disease; Lysosomal storage disease; Ther